Minerva Neurosciences, Inc. (NERV) vs Nkarta, Inc. (NKTX)
A side-by-side comparison of Minerva Neurosciences, Inc. and Nkarta, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NERV
Minerva Neurosciences, Inc.
$3.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NKTX
Nkarta, Inc.
$2.31HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NERV vs NKTX
growth of $100 · dividends reinvested · last 6yNERV -88.2% (-29.9%/yr)NKTX -94.7% (-38.7%/yr)NERV compounded faster over this window
NERV NKTX
NERV vs NKTX: by the numbers
- •NKTX is the larger company ($165M vs $160M market cap).
Metrics side by side
Valuation
| Metric | NERV | NKTX |
|---|---|---|
| P/B ratio | N/A | 0.67 |
Profitability
| Metric | NERV | NKTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -47.36% |
| ROIC | -38.56% | -42.11% |
Growth (annualized)
| Metric | NERV | NKTX |
|---|---|---|
| Total return CAGR (5Y) | -22.14% | -37.28% |
Frequently asked
- How have NERV and NKTX total returns compared?
- Over the past 5 years, NERV delivered -22.14% and NKTX delivered -37.28% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.